Counteracting counterfeiting: Strategies for improving the integrity of the medicinal marketplace in Tanzania
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Presentation
- By: NDOMONDO-SIGONDA, Margareth (Ministry of Health, TFDA, Dar Es Salaam, Tanzania)
The business of medicinal product counterfeiting is intended to make money, with profits subject to economies of scale, i.e., the larger the production run, the lower unit costs; and the greater the market distribution, the greater the income. The largest potential market penetration for counterfeit products is high volume product diversion into.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.